Share Email Print
cover

Proceedings Paper

Radiofrequency ablation for oral and maxillofacial pathologies: A description of the technique
Author(s): Rahul Tandon; Timothy W. Stevens; Alan S. Herford
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Introduction: Radiofrequency ablation (RFA) refers to a high-frequency current that heats and coagulates tissue. In the standard RFA setup, three components are used: a generator, an active electrode, and a dispersive electrode. RFA has garnered support in many of the surgical fields as an alternative to traditional procedures used in tumor removal. Other methods can prove to be more invasive and disfiguring to the patient, in addition to the unwarranted side effects; however, RFA provides a more localized treatment, resulting in decreased co-morbidity to the patient. Currently, its use in the field of oral and maxillofacial surgery is limited, as its technology has not reached our field. By describing its limited use to the optics community, we hope to expand its uses and provide patients with one more alternative treatment option. Methods and Uses: We will describe the use of RFA on three types of pathology: lymphangioma, rhabdomyoscarcoma, oral squamous cell carcinoma, and neoplastic osseous metastasis. The majority of treatments geared towards these pathologies involve surgical resection, followed by reconstruction. However, damage to vital structures coupled with esthetic disfigurement makes RFA a more valuable alternative. In many of the cases, the tumors were successfully removed without recurrence. Conclusion: While the use of RFA has been scarce in our field, we believe that with more exposure it can gain momentum as an alternative to current treatment options. However, there are improvements that we feel can be made, helping to maximize its effectiveness.

Paper Details

Date Published: 4 March 2014
PDF: 12 pages
Proc. SPIE 8926, Photonic Therapeutics and Diagnostics X, 89263T (4 March 2014); doi: 10.1117/12.2042256
Show Author Affiliations
Rahul Tandon, Loma Linda Univ. (United States)
Timothy W. Stevens, Loma Linda Univ. (United States)
Alan S. Herford, Loma Linda Univ. (United States)


Published in SPIE Proceedings Vol. 8926:
Photonic Therapeutics and Diagnostics X
Bernard Choi; Hyun Wook Kang; Brian J. F. Wong; Guillermo J. Tearney; Andreas Mandelis; Nikiforos Kollias; Kenton W. Gregory; Justus F. Ilgner; Haishan Zeng; Laura Marcu, Editor(s)

© SPIE. Terms of Use
Back to Top